Antigens, Neoplasm

"Antigens, Neoplasm" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin.

Descriptor ID	D000951
MeSH Number(s)	D23.050.285
Concept/Terms	Antigens, Neoplasm Antigens, Neoplasm Neoplasm Antigens Tumor Antigens Tumor Antigens Antigens, Tumor

Below are MeSH descriptors whose meaning is more general than "Antigens, Neoplasm".

Chemicals and Drugs [D]
Biological Factors [D23]
Antigens [D23.050]
Antigens, Neoplasm [D23.050.285]

Below are MeSH descriptors whose meaning is related to "Antigens, Neoplasm".

Below are MeSH descriptors whose meaning is more specific than "Antigens, Neoplasm".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Antigens, Neoplasm" by people in this website by year, and whether "Antigens, Neoplasm" was a major or minor topic of these publications.

Bar chart showing 92 publications over 29 distinct years, with a maximum of 9 publications in 2004

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1994	1	2	3
1995	2	0	2
1996	2	0	2
1997	4	0	4
1998	2	0	2
1999	2	0	2
2000	3	1	4
2001	5	0	5
2002	2	2	4
2003	6	1	7
2004	6	3	9
2005	1	2	3
2006	1	2	3
2007	0	3	3
2008	2	1	3
2009	1	3	4
2010	2	0	2
2011	2	4	6
2012	1	1	2
2013	0	1	1
2014	2	0	2
2015	2	1	3
2016	2	0	2
2017	1	1	2
2018	1	2	3
2019	0	4	4
2020	2	0	2
2021	1	1	2
2022	0	1	1

Below are the most recent publications written about "Antigens, Neoplasm" by people in Profiles.

Hathaway-Schrader JD, Norton D, Hastings K, Doonan BP, Fritz ST, Bethard JR, Blum JS, Haque A. GILT Expression in Human Melanoma Cells Enhances Generation of Antigenic Peptides for HLA Class II-Mediated Immune Recognition. Int J Mol Sci. 2022 Jan 19; 23(3).

View in: PubMed
Koirala M, Shashikala HBM, Jeffries J, Wu B, Loftus SK, Zippin JH, Alexov E. Computational Investigation of the pH Dependence of Stability of Melanosome Proteins: Implication for Melanosome formation and Disease. Int J Mol Sci. 2021 Jul 31; 22(15).

View in: PubMed
Johnson DK, Magoffin W, Myers SJ, Finnell JG, Hancock JC, Orton TS, Persaud SP, Christensen KA, Weber KS. CD4 Inhibits Helper T Cell Activation at Lower Affinity Threshold for Full-Length T Cell Receptors Than Single Chain Signaling Constructs. Front Immunol. 2020; 11:561889.

View in: PubMed
Lopez DR, Forcucci JA, O'Connor H, Maize JC. PReferentially expressed antigen in MElanoma (PRAME) expression in BRCA1-associated protein (BAP1)-inactivated melanocytic tumors and deep penetrating nevi: A pilot study. J Cutan Pathol. 2021 Apr; 48(4):597-600.

View in: PubMed
Cao H, Xiao J, Reeves ME, Payne K, Chen CS, Baylink DJ, Marcucci G, Xu Y. Discovery of proangiogenic CD44+mesenchymal cancer stem cells in an acute myeloid leukemia patient's bone marrow. J Hematol Oncol. 2020 06 03; 13(1):63.

View in: PubMed
Manichaikul A, Peres LC, Wang XQ, Barnard ME, Chyn D, Sheng X, Du Z, Tyrer J, Dennis J, Schwartz AG, Cote ML, Peters E, Moorman PG, Bondy M, Barnholtz-Sloan JS, Terry P, Alberg AJ, Bandera EV, Funkhouser E, Wu AH, Pearce CL, Pike M, Setiawan VW, Haiman CA, Palmer JR, LeMarchand L, Wilkens LR, Berchuck A, Doherty JA, Modugno F, Ness R, Moysich K, Karlan BY, Whittemore AS, McGuire V, Sieh W, Lawrenson K, Gayther S, Sellers TA, Pharoah P, Schildkraut JM. Identification of novel epithelial ovarian cancer loci in women of African ancestry. Int J Cancer. 2020 06 01; 146(11):2987-2998.

View in: PubMed
Abelin JG, Harjanto D, Malloy M, Suri P, Colson T, Goulding SP, Creech AL, Serrano LR, Nasir G, Nasrullah Y, McGann CD, Velez D, Ting YS, Poran A, Rothenberg DA, Chhangawala S, Rubinsteyn A, Hammerbacher J, Gaynor RB, Fritsch EF, Greshock J, Oslund RC, Barthelme D, Addona TA, Arieta CM, Rooney MS. Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope Prediction. Immunity. 2019 10 15; 51(4):766-779.e17.

View in: PubMed
Lowe KL, Cole D, Kenefeck R, OKelly I, Lepore M, Jakobsen BK. Novel TCR-based biologics: mobilising T cells to warm 'cold' tumours. Cancer Treat Rev. 2019 Jul; 77:35-43.

View in: PubMed
Wu Y, Yu XZ. Modelling CAR-T therapy in humanized mice. EBioMedicine. 2019 Feb; 40:25-26.

View in: PubMed
Olcina MM, Balanis NG, Kim RK, Aksoy BA, Kodysh J, Thompson MJ, Hammerbacher J, Graeber TG, Giaccia AJ. Mutations in an Innate Immunity Pathway Are Associated with Poor Overall Survival Outcomes and Hypoxic Signaling in Cancer. Cell Rep. 2018 12 26; 25(13):3721-3732.e6.

View in: PubMed

People

Explore

Similar Concepts

Top Journals